Abstract

Olfactory groove schwannomas are exceptionally rare intracranial tumors that present a significant diagnostic challenge, as they are frequently misidentified as meningiomas on preoperative imaging. We report the case of a 44-year-old woman who presented with a two-month history of headache and blurred vision. Neuroimaging revealed a large, dural-based, homogeneously enhancing extra-axial mass in the left frontal region, strongly suggestive of a meningioma. The patient underwent surgical excision of the lesion. Histopathological examination, however, revealed the classic features of a benign schwannoma, including Antoni A and B areas, nuclear palisading, and Verocay bodies. This diagnosis was confirmed by an immunohistochemical profile that was positive for S100 and negative for Epithelial Membrane Antigen. This case underscores the limitations of radiological diagnosis for skull base lesions and highlights the critical role of histopathological and immunohistochemical analysis in achieving a definitive diagnosis, which is paramount for guiding appropriate management.

Introduction

Schwannomas are benign, slow-growing tumors arising from peripheral nerve sheath Schwann cells. While common in the head and neck, particularly the vestibular nerve, intracranial olfactory nerve schwannomas are notably rare [1]. Their non-specific presentation—headaches, visual disturbances, and elevated intracranial pressure—overlaps with other skull base pathologies [2]. The olfactory groove is predominantly associated with meningiomas, extra-axial tumors from arachnoid cap cells. Radiologically, both can appear as well-defined, dural-based, enhancing masses on computed tomography (CT) and magnetic resonance imaging (MRI), increasing pre-operative suspicion for meningioma [3]. This mimicry complicates diagnosis, as surgical planning for excision requires accurate pathological identification.

We present a 44-year-old female with an olfactory groove mass, radiologically classified as a meningioma but histopathologically confirmed as a benign schwannoma. This underscores radiological limitations and histopathology’s essential role in definitive skull base tumor diagnosis.

Case presentation

A 44-year-old right-handed woman presented with a two-month history of headache and blurred vision. Her medical history included hypertension and type 1 diabetes mellitus. She reported gradually worsening intermittent headache and bilateral visual blurring, more pronounced in the right eye. Symptoms exacerbated with physical exertion and were unrelieved by analgesics, leading to her referral. Examination revealed a conscious, alert patient with right eye proptosis. Visual acuity was 6/6 (left eye) and 6/9 (right eye). Fundoscopy identified bilateral Grade 3 papilledema. Non-contrast brain CT demonstrated a well-defined, isodense, dural-based extra-axial lesion in the left frontal region with a cystic component, measuring approximately 5.5 × 4.3 × 4.2 cm. It was associated with mild perilesional edema, mass effect, and a subtle contralateral falx shift. The initial impression was an atypical meningioma (Fig. 1). Subsequent MRI confirmed a large, falcine-based lesion that appeared isointense on T1- (Fig. 2) and T2-weighted images, demonstrating intense homogeneous enhancement post-contrast (Fig. 3). Signal voids suggested calcifications. The patient underwent gross total excision via a bilateral frontal craniotomy. The tumor was intradural and extra-axial, elevating the frontal lobe and was easily accessible; therefore, neither neuronavigation nor other intra-operative localization aids were utilized. Intraoperatively, the olfactory tract could not be clearly identified. A gap in the anterior cranial base was noted, but as there was no evidence of dural invasion or cerebrospinal fluid leak, no sealant was required. Gross examination of the resected specimen revealed a well-circumscribed, white nodule. Microscopically, sections showed benign spindle cell proliferation with alternating Antoni A and Antoni B areas (Fig. 4). Antoni A regions displayed nuclear palisading and Verocay bodies (Fig. 5), while Antoni B areas were edematous and myxoid (Fig. 6). No mitotic figures or atypia were seen. The definitive diagnosis was a benign olfactory groove schwannoma, notable given the initial radiological suspicion of meningioma. Her postoperative course was uneventful. A postoperative non-contrast CT brain obtained 48 hours after surgery confirmed gross total resection (Fig. 7). She was discharged with scheduled follow-up to monitor recovery and visual symptoms.

Preoperative CT brain without contrast (axial view) showing a well-circumscribed mass in the right frontal lobe resting on the falx cerebri, causing leftward midline shift with associated vasogenic edema and mass effect.
Figure 1

Preoperative CT brain without contrast (axial view) showing a well-circumscribed mass in the right frontal lobe resting on the falx cerebri, causing leftward midline shift with associated vasogenic edema and mass effect.

MRI brain without IV contrast (T1 sequence) showing a well-circumscribed hypointense mass with areas of heterogeneity occupying the right frontal lobe, closely related to the midline structures and falx cerebri.
Figure 2

MRI brain without IV contrast (T1 sequence) showing a well-circumscribed hypointense mass with areas of heterogeneity occupying the right frontal lobe, closely related to the midline structures and falx cerebri.

MRI brain with IV contrast (sagittal midline view) showing a homogeneously enhancing mass based on the cribriform plate of the ethmoid, displacing the frontal lobe upward and posteriorly.
Figure 3

MRI brain with IV contrast (sagittal midline view) showing a homogeneously enhancing mass based on the cribriform plate of the ethmoid, displacing the frontal lobe upward and posteriorly.

Photomicrograph showing a well-circumscribed, partially encapsulated lesion composed of hypercellular Antoni a areas admixed with myxoid hypocellular Antoni B areas (H&E, ×100).
Figure 4

Photomicrograph showing a well-circumscribed, partially encapsulated lesion composed of hypercellular Antoni a areas admixed with myxoid hypocellular Antoni B areas (H&E, ×100).

Photomicrograph of hypercellular Antoni a areas showing interlacing bundles of spindle-shaped cells with nuclear palisading (H&E, ×400).
Figure 5

Photomicrograph of hypercellular Antoni a areas showing interlacing bundles of spindle-shaped cells with nuclear palisading (H&E, ×400).

Photomicrograph of hypocellular Antoni B areas showing few cuboidal cells separated by myxoid stroma (H&E, ×400).
Figure 6

Photomicrograph of hypocellular Antoni B areas showing few cuboidal cells separated by myxoid stroma (H&E, ×400).

Post-op CT brain showing total excision of the tumor leaving mild post-op oedema at tumor bed.
Figure 7

Post-op CT brain showing total excision of the tumor leaving mild post-op oedema at tumor bed.

Discussion

Olfactory groove schwannomas (OGS) are rare and diagnostically challenging, as the olfactory nerve contains few Schwann cells, the typical origin of schwannomas. A 44-year-old woman had a large left frontal extra-axial lesion, initially diagnosed radiologically as a meningioma but later confirmed histopathologically as a benign schwannoma, illustrating this diagnostic dilemma and aligning with literature trends [4–7].

The initial radiological diagnosis of meningioma was understandable. The lesion demonstrated features of an atypical meningioma on CT and MRI: a well-defined, dural-based, extra-axial mass with significant homogeneous contrast enhancement, edema, and mass effect [8]. This diagnostic error is common; most OGS cases are misdiagnosed preoperatively as olfactory groove meningiomas [4–7, 9–12]. Shared radiological features include a dural base, isointensity on T1/T2 sequences, and homogeneous enhancement [4, 8, 9]. However, certain subtle indicators can suggest schwannoma. Cystic components, as in our case and others [4, 8], and the absence of hyperostosis or a prominent dural tail [10, 11], favor OGS. Bone erosion, noted by Shenoy et al. [12] and Murakami et al. [13], is also more indicative of slow-growing schwannomas.

Definitive diagnosis relies on histopathology and immunohistochemistry. Microscopy revealed the classic biphasic pattern of benign schwannoma with Antoni A and B areas, nuclear palisading, and Verocay bodies, a pattern foundational to diagnosis [4–7, 9, 10]. Immunohistochemistry is crucial for differentiation. The tumor cells showed strong, diffuse S-100 protein positivity [4–7, 9] and were negative for Epithelial Membrane Antigen (EMA), which is typically positive in meningiomas [5–7, 9]. This S100-positive/EMA-negative profile is definitive for schwannoma. Additional markers like SOX-10 [4] or CD57 [5, 9] can further distinguish OGS from other rare tumors.

The patient presented with a two-month history of headaches, blurred vision, and papilledema. While anosmia is considered a key symptom, our review found diverse presentations (Table 1). Many patients have olfactory dysfunction [14–16], but a significant number, including ours and others [10, 17], have preserved smell. This suggests symptoms often arise from mass effect on adjacent structures like the optic apparatus and frontal lobes, causing visual issues, headaches, and seizures, rather than direct olfactory nerve involvement [7, 10, 18]. Table 2 summarizes key features from the literature.

Table 1

Patient demographics, clinical presentation, and olfactory outcomes.

Study IDAgeSexMain symptomPre-op olfactionPost-op olfactionFollow-up (Recurrence)
Sousa 202516MHeadaches, hyposmia, convulsionHyposmiaRestored2 years (No)
Vp 202232MProgressive headachesAnosmia absentAsymptomatic2 years (No)
Masuda 202013FHeadacheNormalNA5 years (No)
Taha 201856MIncidental (RTA), anosmiaAnosmiaNo improvementNA (No)
Liby 201613FSeizures, papilloedema, vision impairmentDiminished senseResidual anosmia6 months (No)
Manto 201639FHeadache, loss of smellAnosmia (right)NA4 months (No)
Bohoun 2016–126MIncidental findingAnosmia (right)UnchangedNA (No)
Bohoun 2016–224FSyncopeAnosmia (right)UnchangedNA (No)
Quick 2015–164FHeadacheAnosmia (left)NANA (No)
Quick 2015–245FIncidental finding, hyposmiaHyposmiaNANA (No)
Kim 201549FHeadache, nausea, vomitingPreservedPreserved19 months (No)
Choi 200939FAnosmia, frontal headacheAnosmiaImprovedNA
Mirone 200938MHeadache, vomiting, visual impairmentSlight hyposmiaNA18 months (No)
Figueiredo 200949MHeadache, loss of smellBilateral anosmiaNANA
Adachi 200749FGeneralized seizuresNormalNA2 years (No)
Murakami 200430MIntermittent headacheNormalNANA (No)
Shenoy 200455MGeneralized seizuresPreservedNANA (No)
Praharaj 199945MHeadaches, generalized seizuresNANANA (No)
Ulrich 197819MEpileptic seizures, visual lossUnilateral anosmiaNA3 years (No)
Study IDAgeSexMain symptomPre-op olfactionPost-op olfactionFollow-up (Recurrence)
Sousa 202516MHeadaches, hyposmia, convulsionHyposmiaRestored2 years (No)
Vp 202232MProgressive headachesAnosmia absentAsymptomatic2 years (No)
Masuda 202013FHeadacheNormalNA5 years (No)
Taha 201856MIncidental (RTA), anosmiaAnosmiaNo improvementNA (No)
Liby 201613FSeizures, papilloedema, vision impairmentDiminished senseResidual anosmia6 months (No)
Manto 201639FHeadache, loss of smellAnosmia (right)NA4 months (No)
Bohoun 2016–126MIncidental findingAnosmia (right)UnchangedNA (No)
Bohoun 2016–224FSyncopeAnosmia (right)UnchangedNA (No)
Quick 2015–164FHeadacheAnosmia (left)NANA (No)
Quick 2015–245FIncidental finding, hyposmiaHyposmiaNANA (No)
Kim 201549FHeadache, nausea, vomitingPreservedPreserved19 months (No)
Choi 200939FAnosmia, frontal headacheAnosmiaImprovedNA
Mirone 200938MHeadache, vomiting, visual impairmentSlight hyposmiaNA18 months (No)
Figueiredo 200949MHeadache, loss of smellBilateral anosmiaNANA
Adachi 200749FGeneralized seizuresNormalNA2 years (No)
Murakami 200430MIntermittent headacheNormalNANA (No)
Shenoy 200455MGeneralized seizuresPreservedNANA (No)
Praharaj 199945MHeadaches, generalized seizuresNANANA (No)
Ulrich 197819MEpileptic seizures, visual lossUnilateral anosmiaNA3 years (No)
Table 1

Patient demographics, clinical presentation, and olfactory outcomes.

Study IDAgeSexMain symptomPre-op olfactionPost-op olfactionFollow-up (Recurrence)
Sousa 202516MHeadaches, hyposmia, convulsionHyposmiaRestored2 years (No)
Vp 202232MProgressive headachesAnosmia absentAsymptomatic2 years (No)
Masuda 202013FHeadacheNormalNA5 years (No)
Taha 201856MIncidental (RTA), anosmiaAnosmiaNo improvementNA (No)
Liby 201613FSeizures, papilloedema, vision impairmentDiminished senseResidual anosmia6 months (No)
Manto 201639FHeadache, loss of smellAnosmia (right)NA4 months (No)
Bohoun 2016–126MIncidental findingAnosmia (right)UnchangedNA (No)
Bohoun 2016–224FSyncopeAnosmia (right)UnchangedNA (No)
Quick 2015–164FHeadacheAnosmia (left)NANA (No)
Quick 2015–245FIncidental finding, hyposmiaHyposmiaNANA (No)
Kim 201549FHeadache, nausea, vomitingPreservedPreserved19 months (No)
Choi 200939FAnosmia, frontal headacheAnosmiaImprovedNA
Mirone 200938MHeadache, vomiting, visual impairmentSlight hyposmiaNA18 months (No)
Figueiredo 200949MHeadache, loss of smellBilateral anosmiaNANA
Adachi 200749FGeneralized seizuresNormalNA2 years (No)
Murakami 200430MIntermittent headacheNormalNANA (No)
Shenoy 200455MGeneralized seizuresPreservedNANA (No)
Praharaj 199945MHeadaches, generalized seizuresNANANA (No)
Ulrich 197819MEpileptic seizures, visual lossUnilateral anosmiaNA3 years (No)
Study IDAgeSexMain symptomPre-op olfactionPost-op olfactionFollow-up (Recurrence)
Sousa 202516MHeadaches, hyposmia, convulsionHyposmiaRestored2 years (No)
Vp 202232MProgressive headachesAnosmia absentAsymptomatic2 years (No)
Masuda 202013FHeadacheNormalNA5 years (No)
Taha 201856MIncidental (RTA), anosmiaAnosmiaNo improvementNA (No)
Liby 201613FSeizures, papilloedema, vision impairmentDiminished senseResidual anosmia6 months (No)
Manto 201639FHeadache, loss of smellAnosmia (right)NA4 months (No)
Bohoun 2016–126MIncidental findingAnosmia (right)UnchangedNA (No)
Bohoun 2016–224FSyncopeAnosmia (right)UnchangedNA (No)
Quick 2015–164FHeadacheAnosmia (left)NANA (No)
Quick 2015–245FIncidental finding, hyposmiaHyposmiaNANA (No)
Kim 201549FHeadache, nausea, vomitingPreservedPreserved19 months (No)
Choi 200939FAnosmia, frontal headacheAnosmiaImprovedNA
Mirone 200938MHeadache, vomiting, visual impairmentSlight hyposmiaNA18 months (No)
Figueiredo 200949MHeadache, loss of smellBilateral anosmiaNANA
Adachi 200749FGeneralized seizuresNormalNA2 years (No)
Murakami 200430MIntermittent headacheNormalNANA (No)
Shenoy 200455MGeneralized seizuresPreservedNANA (No)
Praharaj 199945MHeadaches, generalized seizuresNANANA (No)
Ulrich 197819MEpileptic seizures, visual lossUnilateral anosmiaNA3 years (No)
Table 2

Surgical, radiological, and histopathological characteristics.

Study IDTumor locationKey imaging featuresSurgical approachExtent of resectionOlfactory nerve intraoperative findingFinal diagnosis (Confirmed by IHC)
Sousa 2025Right frontobasalCystic & solid; intense enhancementTranscorticalCompleteNASchwannoma
Vp 2022Right frontobasalHomogeneous enhancement; peripheral edema (T2)MinipterionalRadicalRight tract isolatedOlfactory groove schwannoma
Masuda 2020Anterior skull baseT1 low, T2 high; strong enhancementInterhemisphericGross TotalNAOlfactory groove schwannoma
Taha 2018Right frontal (intra-axial)MRI not performedTranscorticalCompleteNerves not identifiedSchwannoma
Liby 2016Midline anterior fossaHeterogeneous (solid-cystic)FrontolateralTotalRight nerve/bulb absentOlfactory groove schwannoma
Manto 2016Right anterior fossaT1 hypointense, T2 hyperintenseBilateral frontalTotalRight tract not identifiable; left intactTypical Schwannoma
Bohoun 2016–1Right anterior fossaT1 hypointense, T2 hyperintenseFrontobasalTotalContinuity with right bulbSchwannoma-like tumor
Bohoun 2016–2Right subfrontalT1 hypointense, T2 hyperintenseFrontalGross TotalArose from right bulbSchwannoma-like tumor
Quick 2015–1Frontal base, nasal invasionSolid mass with cystic areasBifrontalGross TotalLeft nerve destroyedSchwannoma WHO I
Quick 2015–2Olfactory grooveContrast-enhancingFronto-lateralGross TotalLeft nerve destroyedSchwannoma WHO I
Kim 2015Left frontal baseT1 hypointense, T2 cystic; variegating enhancementSubfrontalCompleteNerve preservedOlfactory groove schwannoma
Choi 2009Ethmoid to right frontalInhomogeneous; solid & rim enhancementBifrontal, subfrontalTotalOlfactory bulb involvedSchwannoma
Mirone 2009Olfactory grooveCystic mass with edema; strong enhancementFrontal, subfrontalCompleteLeft bulb/tract not identifiable; right preservedTypical Schwannoma
Figueiredo 2009Olfactory grooveT1 isointense, T2 hyperintenseNACompleteBoth tracts involvedSchwannoma
Adachi 2007Olfactory grooveT1 low, T2 high; partial enhancementLeft frontalTotalNerve stretched thinSchwannoma
Murakami 2004Left anterior skull baseHypovascular (angiography)Left frontalTotalLeft bulb involved; proximal tract intactSchwannoma
Shenoy 2004Midline anterior fossaT1 hypointense, T2 hyperintense; honeycomb enh.FrontotemporalTotalIpsilateral bulb thinned; contralateral preservedSchwannoma
Praharaj 1999Right frontobasalUniformly enhancing (CT)BifrontalTotalBulbs not identifiedHyalinised Schwannoma
Ulrich 1978Right anterior fossaNAFrontalTotalRight bulb likely destroyedSchwannoma
Study IDTumor locationKey imaging featuresSurgical approachExtent of resectionOlfactory nerve intraoperative findingFinal diagnosis (Confirmed by IHC)
Sousa 2025Right frontobasalCystic & solid; intense enhancementTranscorticalCompleteNASchwannoma
Vp 2022Right frontobasalHomogeneous enhancement; peripheral edema (T2)MinipterionalRadicalRight tract isolatedOlfactory groove schwannoma
Masuda 2020Anterior skull baseT1 low, T2 high; strong enhancementInterhemisphericGross TotalNAOlfactory groove schwannoma
Taha 2018Right frontal (intra-axial)MRI not performedTranscorticalCompleteNerves not identifiedSchwannoma
Liby 2016Midline anterior fossaHeterogeneous (solid-cystic)FrontolateralTotalRight nerve/bulb absentOlfactory groove schwannoma
Manto 2016Right anterior fossaT1 hypointense, T2 hyperintenseBilateral frontalTotalRight tract not identifiable; left intactTypical Schwannoma
Bohoun 2016–1Right anterior fossaT1 hypointense, T2 hyperintenseFrontobasalTotalContinuity with right bulbSchwannoma-like tumor
Bohoun 2016–2Right subfrontalT1 hypointense, T2 hyperintenseFrontalGross TotalArose from right bulbSchwannoma-like tumor
Quick 2015–1Frontal base, nasal invasionSolid mass with cystic areasBifrontalGross TotalLeft nerve destroyedSchwannoma WHO I
Quick 2015–2Olfactory grooveContrast-enhancingFronto-lateralGross TotalLeft nerve destroyedSchwannoma WHO I
Kim 2015Left frontal baseT1 hypointense, T2 cystic; variegating enhancementSubfrontalCompleteNerve preservedOlfactory groove schwannoma
Choi 2009Ethmoid to right frontalInhomogeneous; solid & rim enhancementBifrontal, subfrontalTotalOlfactory bulb involvedSchwannoma
Mirone 2009Olfactory grooveCystic mass with edema; strong enhancementFrontal, subfrontalCompleteLeft bulb/tract not identifiable; right preservedTypical Schwannoma
Figueiredo 2009Olfactory grooveT1 isointense, T2 hyperintenseNACompleteBoth tracts involvedSchwannoma
Adachi 2007Olfactory grooveT1 low, T2 high; partial enhancementLeft frontalTotalNerve stretched thinSchwannoma
Murakami 2004Left anterior skull baseHypovascular (angiography)Left frontalTotalLeft bulb involved; proximal tract intactSchwannoma
Shenoy 2004Midline anterior fossaT1 hypointense, T2 hyperintense; honeycomb enh.FrontotemporalTotalIpsilateral bulb thinned; contralateral preservedSchwannoma
Praharaj 1999Right frontobasalUniformly enhancing (CT)BifrontalTotalBulbs not identifiedHyalinised Schwannoma
Ulrich 1978Right anterior fossaNAFrontalTotalRight bulb likely destroyedSchwannoma
Table 2

Surgical, radiological, and histopathological characteristics.

Study IDTumor locationKey imaging featuresSurgical approachExtent of resectionOlfactory nerve intraoperative findingFinal diagnosis (Confirmed by IHC)
Sousa 2025Right frontobasalCystic & solid; intense enhancementTranscorticalCompleteNASchwannoma
Vp 2022Right frontobasalHomogeneous enhancement; peripheral edema (T2)MinipterionalRadicalRight tract isolatedOlfactory groove schwannoma
Masuda 2020Anterior skull baseT1 low, T2 high; strong enhancementInterhemisphericGross TotalNAOlfactory groove schwannoma
Taha 2018Right frontal (intra-axial)MRI not performedTranscorticalCompleteNerves not identifiedSchwannoma
Liby 2016Midline anterior fossaHeterogeneous (solid-cystic)FrontolateralTotalRight nerve/bulb absentOlfactory groove schwannoma
Manto 2016Right anterior fossaT1 hypointense, T2 hyperintenseBilateral frontalTotalRight tract not identifiable; left intactTypical Schwannoma
Bohoun 2016–1Right anterior fossaT1 hypointense, T2 hyperintenseFrontobasalTotalContinuity with right bulbSchwannoma-like tumor
Bohoun 2016–2Right subfrontalT1 hypointense, T2 hyperintenseFrontalGross TotalArose from right bulbSchwannoma-like tumor
Quick 2015–1Frontal base, nasal invasionSolid mass with cystic areasBifrontalGross TotalLeft nerve destroyedSchwannoma WHO I
Quick 2015–2Olfactory grooveContrast-enhancingFronto-lateralGross TotalLeft nerve destroyedSchwannoma WHO I
Kim 2015Left frontal baseT1 hypointense, T2 cystic; variegating enhancementSubfrontalCompleteNerve preservedOlfactory groove schwannoma
Choi 2009Ethmoid to right frontalInhomogeneous; solid & rim enhancementBifrontal, subfrontalTotalOlfactory bulb involvedSchwannoma
Mirone 2009Olfactory grooveCystic mass with edema; strong enhancementFrontal, subfrontalCompleteLeft bulb/tract not identifiable; right preservedTypical Schwannoma
Figueiredo 2009Olfactory grooveT1 isointense, T2 hyperintenseNACompleteBoth tracts involvedSchwannoma
Adachi 2007Olfactory grooveT1 low, T2 high; partial enhancementLeft frontalTotalNerve stretched thinSchwannoma
Murakami 2004Left anterior skull baseHypovascular (angiography)Left frontalTotalLeft bulb involved; proximal tract intactSchwannoma
Shenoy 2004Midline anterior fossaT1 hypointense, T2 hyperintense; honeycomb enh.FrontotemporalTotalIpsilateral bulb thinned; contralateral preservedSchwannoma
Praharaj 1999Right frontobasalUniformly enhancing (CT)BifrontalTotalBulbs not identifiedHyalinised Schwannoma
Ulrich 1978Right anterior fossaNAFrontalTotalRight bulb likely destroyedSchwannoma
Study IDTumor locationKey imaging featuresSurgical approachExtent of resectionOlfactory nerve intraoperative findingFinal diagnosis (Confirmed by IHC)
Sousa 2025Right frontobasalCystic & solid; intense enhancementTranscorticalCompleteNASchwannoma
Vp 2022Right frontobasalHomogeneous enhancement; peripheral edema (T2)MinipterionalRadicalRight tract isolatedOlfactory groove schwannoma
Masuda 2020Anterior skull baseT1 low, T2 high; strong enhancementInterhemisphericGross TotalNAOlfactory groove schwannoma
Taha 2018Right frontal (intra-axial)MRI not performedTranscorticalCompleteNerves not identifiedSchwannoma
Liby 2016Midline anterior fossaHeterogeneous (solid-cystic)FrontolateralTotalRight nerve/bulb absentOlfactory groove schwannoma
Manto 2016Right anterior fossaT1 hypointense, T2 hyperintenseBilateral frontalTotalRight tract not identifiable; left intactTypical Schwannoma
Bohoun 2016–1Right anterior fossaT1 hypointense, T2 hyperintenseFrontobasalTotalContinuity with right bulbSchwannoma-like tumor
Bohoun 2016–2Right subfrontalT1 hypointense, T2 hyperintenseFrontalGross TotalArose from right bulbSchwannoma-like tumor
Quick 2015–1Frontal base, nasal invasionSolid mass with cystic areasBifrontalGross TotalLeft nerve destroyedSchwannoma WHO I
Quick 2015–2Olfactory grooveContrast-enhancingFronto-lateralGross TotalLeft nerve destroyedSchwannoma WHO I
Kim 2015Left frontal baseT1 hypointense, T2 cystic; variegating enhancementSubfrontalCompleteNerve preservedOlfactory groove schwannoma
Choi 2009Ethmoid to right frontalInhomogeneous; solid & rim enhancementBifrontal, subfrontalTotalOlfactory bulb involvedSchwannoma
Mirone 2009Olfactory grooveCystic mass with edema; strong enhancementFrontal, subfrontalCompleteLeft bulb/tract not identifiable; right preservedTypical Schwannoma
Figueiredo 2009Olfactory grooveT1 isointense, T2 hyperintenseNACompleteBoth tracts involvedSchwannoma
Adachi 2007Olfactory grooveT1 low, T2 high; partial enhancementLeft frontalTotalNerve stretched thinSchwannoma
Murakami 2004Left anterior skull baseHypovascular (angiography)Left frontalTotalLeft bulb involved; proximal tract intactSchwannoma
Shenoy 2004Midline anterior fossaT1 hypointense, T2 hyperintense; honeycomb enh.FrontotemporalTotalIpsilateral bulb thinned; contralateral preservedSchwannoma
Praharaj 1999Right frontobasalUniformly enhancing (CT)BifrontalTotalBulbs not identifiedHyalinised Schwannoma
Ulrich 1978Right anterior fossaNAFrontalTotalRight bulb likely destroyedSchwannoma

The patient’s uneventful postoperative recovery and planned monitoring align with the generally excellent prognosis of OGS after gross total resection. The literature shows minimal recurrence rates, with no recurrences in reviewed cases despite follow-ups ranging from months to five years [4, 5, 10, 17, 19]. The straightforward surgical access and gross total resection achieved in this case, without the need for complex reconstruction, further support the favorable management outcome for these lesions.

Conclusion

The diagnostic trajectory of this patient highlights the necessity of clinical vigilance in the evaluation of anterior cranial fossa masses. The radiological findings indicated a meningioma; however, the definitive diagnosis of an olfactory groove schwannoma was confirmed through detailed histopathological examination, which revealed classic schwannoma architecture supported by a definitive S100-positive and EMA-negative immunohistochemical profile. This case highlights the significance of olfactory groove schwannomas, which, despite their rarity, must be considered in diagnostics, as precise identification is essential for informing surgical management. This case demonstrates that gross total resection provides an excellent prognosis, with the possibility of definitive cure and long-term disease control.

Conflicts of interest

The authors have no conflicts of interest to disclose.

Funding

We received no funding in any form.

Ethical approval

Ethics clearance was not necessary since the University waives ethics approval for publication of case reports involving no patients’ images, and the case report is not containing any personal information. The ethical approval is obligatory for research that involve human or animal experiments.

Consent of patient

Written informed consent was obtained from the patient for publication of this case report and accompanying images.

Guarantor

The corresponding author.

References

1.

Taha
 
MM
,
AlBakry
 
A
,
ElSheikh
 
M
 et al.  
Olfactory nerve schwannoma: a case report and review of the literature
.
Surg J
 
2018
;
4
:
e164
6
.

2.

Geethapriya
 
S
,
Govindaraj
 
J
,
Raghavan
 
B
 et al.  
Cranial nerve schwannoma – a pictorial essay
.
Indian J Radiol Imaging
 
2020
;
30
:
116
25
.

3.

Louis
 
DN
,
Perry
 
A
,
Wesseling
 
P
 et al.  
The 2021 WHO classification of Tumors of the central nervous system: a summary
.
Neuro Oncol
 
2021
;
23
:
1231
.

4.

de
 
Sousa
 
R
,
Rodrigues
 
FM
,
Maia
 
C
 et al.  
Olfactory schwannoma in an adolescent: a case report
.
Pediatr Radiol
 
2025
;
55
:
1029
33
.

5.

Vp
 
F
,
Papa
 
V
,
C
 
T
 et al.  
Olfactory nerve schwannoma: how human anatomy and electron microscopy can help to solve an intriguing scientific puzzle
.
Ultrastruct Pathol
 
2022
;
46
:
490
6
.

6.

Liby
 
P
,
Zamecnik
 
J
,
Kyncl
 
M
 et al.  
An olfactory groove schwannoma with a pseudocyst compressing the basal ganglia, internal capsule and optic tracts
.
Childs Nerv Syst
 
2016
;
32
:
2269
73
.

7.

Manto
 
A
,
Manzo
 
G
,
De Gennaro
 
A
 et al.  
An enigmatic clinical entity: a new case of olfactory schwannoma
.
Neuroradiol J
 
2016
;
29
:
174
8
.

8.

Mirone
 
G
,
Natale
 
M
,
Scuotto
 
A
 et al.  
Solitary olfactory groove schwannoma
.
J Clin Neurosci
 
2009
;
16
:
454
6
.

9.

Masuda
 
H
,
Nemoto
 
M
,
Okonogi
 
S
 et al.  
Utility of Schwann/2E and Sox10 in distinguishing CD57-negative olfactory groove schwannoma from olfactory ensheathing cell tumor: a case report and review of the literature
.
Neuropathology
 
2020
;
40
:
373
8
.

10.

Adachi
 
K
,
Yoshida
 
K
,
Miwa
 
T
 et al.  
Olfactory schwannoma
.
Acta Neurochir
 
2007
;
149
:
605
10
.

11.

Praharaj
 
SS
,
Vajramani
 
GV
,
Santosh
 
V
 et al.  
Solitary olfactory groove schwannoma: case report with review of the literature
.
Clin Neurol Neurosurg
 
1999
;
101
:
26
8
.

12.

Shenoy
 
SN
,
Raja
 
A
.
Cystic olfactory groove schwannoma
.
Neurol India
 
2004
;
52
:
261
2
.

13.

Murakami
 
M
,
Tsukahara
 
T
,
Hatano
 
T
 et al.  
Olfactory groove schwannoma—case report—
.
Neurol Med Chir (Tokyo)
 
2004
;
44
:
191
4
.

14.

Taha
 
MM
,
Almenshawy
 
HA
,
Ezzat
 
M
 et al.  
Migration of distal end of VP shunt into the scrotum: a management review
.
Surg J
 
2022
;
8
:
1
2
.

15.

Bohoun
 
CA
,
Terakawa
 
Y
,
Goto
 
T
 et al.  
Schwannoma-like tumor in the anterior cranial fossa immunonegative for Leu7 but immunopositive for Schwann/2E
.
Neuropathology
 
2017
;
37
:
265
71
.

16.

Figueiredo
 
EG
,
Gomes
 
MQT
,
Soga
 
Y
 et al.  
A rare case of olfactory groove schwannoma
.
Arq Neuropsiquiatr
 
2009
;
67
:
534
,
535
.

17.

Kim
 
DY
,
Yoon
 
PH
,
Kie
 
JH
 et al.  
The olfactory groove schwannoma attached to the cribriform plate: a case report
.
Brain Tumor Res Treat
 
2015
;
3
:
56
9
.

18.

Ulrich
 
J
,
Lévy
 
A
,
Pfister
 
C
.
Schwannoma of the olfactory groove
.
Acta Neurochir
 
1978
;
40
:
315
21
.

19.

Quick
 
J
,
Hattingen
 
E
,
Delbridge
 
C
 et al.  
Schwannoma of the olfactory nerve. Report of two cases and review of the literature
.
Clin Neurol Neurosurg
 
2015
;
132
:
44
6
.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.